In this episode, we get an insight into the ATMP 2030 innovation environment. What is ATMP 2030? Which actors are involved, and what challenges await ATMP companies in the coming years? To answer these questions, Plantvision's Karin Tördahl interviewed Ewa Ellis from the Karolinska Center for Cell Therapy at Karolinska University Hospital. Ewa is also part of the core team of ATMP Sweden - the national network for Sweden's activities in Pharma based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs).